Latest News from Pro PG

Pro Pharmaceuticals Group will attend Expopharm 2025 in Düsseldorf from 16–18 September. Directors Sandip Manku and Lukasz Nowaczek will be meeting long-term partners and exploring new global supplier and customer opportunities at Europe’s leading pharmacy trade fair.

Pro Pharmaceuticals Group continues to strengthen its position as a trusted partner in global pharmaceutical supply, with a growing portfolio of structured export agreements supporting clinical research and healthcare delivery in Europe and beyond. Our ability to source registered pharmaceutical products from major global markets — including Europe and the United States — enables us to meet complex clinical and regulatory requirements for comparator and specialty medicines. L

Due to the ongoing shortage of RIFADIN (Rifampicin 300 mg), Pro Pharmaceuticals Group has secured an alternative product from Lupin USA. Approved under TGA Section 19A until 31 March 2026, the product is now available in both 30- and 60-capsule presentations.